Mednax Non Current Liabilities Total from 2010 to 2025
| MD Stock | USD 14.16 0.86 5.73% |
Non Current Liabilities Total | First Reported 1994-12-31 | Previous Quarter 971.3 M | Current Value 953.7 M | Quarterly Volatility 853.6 M |
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.7 M, Interest Expense of 25.1 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.52, Dividend Yield of 0.0 or PTB Ratio of 1.36. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
Mednax | Non Current Liabilities Total |
Latest Mednax's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Mednax Inc over the last few years. It is Mednax's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
Mednax Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 1,264,712,246 | |
| Geometric Mean | 710,559,506 | |
| Coefficient Of Variation | 63.30 | |
| Mean Deviation | 689,451,410 | |
| Median | 1,082,030,000 | |
| Standard Deviation | 800,533,292 | |
| Sample Variance | 640853.6T | |
| Range | 2.4B | |
| R-Value | 0.33 | |
| Mean Square Error | 613985T | |
| R-Squared | 0.11 | |
| Significance | 0.22 | |
| Slope | 54,692,007 | |
| Total Sum of Squares | 9612803.3T |
Mednax Non Current Liabilities Total History
About Mednax Financial Statements
Mednax stakeholders use historical fundamental indicators, such as Mednax's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although Mednax investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednax's assets and liabilities are reflected in the revenues and expenses on Mednax's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednax Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 953.7 M | 741.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Mednax Correlation against competitors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (1.19) | Revenue Per Share | Quarterly Revenue Growth 0.012 | Return On Assets |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.